Minnesota's two licensed medical marijuana manufacturers posted millions of dollars in losses in their first full year of operations, according to financial documents obtained by The Associated Press.
Minnesota Medical Solutions posted a $3 million loss in 2015, a period that saw the rush to build up facilities, the growing and cultivating of the plants and the first six months of legal medical marijuana sales. The company also said it lost more than $542,000 in 2014.
The other manufacturer, LeafLine Labs, lost roughly $2.2 million in 2015. Their audit does not include information from 2014. The AP obtained copies of the documents through an open records request.
The heavy losses illustrate the difficulty of running a medical marijuana business in Minnesota's tightly regulated structure and confirm some fears among patient advocates that the program can't survive long-term.
Read more at AP
Related Articles → See More
-
Staff turnover and process consistency: a growing challenge for European cannabis operators
-
Leveraging soil science for commercial outdoor success
-
Researchers identify optimal magnesium levels, finding different responses than N, P, and K
-
NL: Origins of THC, CBD and CBC in cannabis revealed
-
Data collection as an operational tool in commercial cannabis cultivation
-
Genetic selection as a trade off driven process
-
As margins tighten, cannabis compliance tools face a usability test
-
“We wanted to solve the actual problems growers deal with every day”
-
Mother room discipline defines risk in large scale cannabis cultivation
-
Scientists revive prehistoric cannabis enzymes and uncover more medical uses